Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Voglow 0.3 GM2 Tablets are used in the therapy of type 2 diabetes mellitus. This combination of three medications—glimepiride, metformin, and Voglibose—helps patients who are not sufficiently controlled by diet and exercise alone to manage their blood sugar levels.
Voglow 0.3 GM2 Tablet is a combination drug used in type 2 diabetes management. It includes:
This combination helps control blood sugar levels effectively but requires careful monitoring and adjustment based on individual responses and side effects.
strip of 10 tablets
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take Voglow 0.3 GM2 Tablet exactly as prescribed by your doctor. It is usually taken with meals to reduce gastrointestinal side effects. Swallow the tablet whole with a glass of water. Do not chew or crush the tablet. Your doctor will determine the appropriate dosage based on your blood sugar levels and personal needs.
Related Warnings
Alcohol intake should be restricted while using Voglow 0.3 GM2 Tablet, as it can interfere with blood sugar regulation and increase the risk of hypoglycemia. Discuss your alcohol consumption with your doctor to ensure safe levels of intake.
Voglow 0.3 GM2 Tablet is generally not recommended during pregnancy due to its unclear safety profile. Inform your doctor if you are pregnant or planning to become pregnant so that they can advise alternative methods for managing diabetes during pregnancy.
The safety of Voglow 0.3 GM2 Tablet during breastfeeding is not well-established. Consult your doctor to discuss potential risks and benefits and to explore alternative treatments if you are breastfeeding or planning to breastfeed.
Voglow 0.3 GM2 Tablet may affect some individuals, especially if blood sugar levels are too low, potentially causing dizziness or blurred vision. If you experience these symptoms, avoid driving or operating machinery until you feel better. Regular blood sugar monitoring can help mitigate these risks.
Patients with impaired kidney function may require dosage adjustments of Voglow 0.3 GM2 Tablet, as the kidneys metabolize the medications. Regular monitoring of kidney function is important. Consult your doctor if you have any kidney issues for specific guidance.
Liver function can also impact the metabolism of Voglow 0.3 GM2 Tablet. Those with liver conditions may need alternative medications or dosage adjustments. Regular liver function tests are crucial, and any symptoms of liver problems should be reported to your doctor immediately.
Q:What should I do if I miss a dose?
A:Take Voglow 0.3 GM2 Tablet as soon as you remember. If the next dose is approaching, skip the missed dose and continue with your regular schedule. Do not double up to make up for a missed dose.
Q:Can I combine Voglow 0.3 GM2 Tablet with another prescription?A:Voglow 0.3 GM2 Tablet may interact with some other drugs. Inform your doctor about all medications, including over-the-counter drugs and supplements, to prevent potential interactions.
Q:How should I store Voglow 0.3 GM2 Tablets?A:Store Voglow 0.3 GM2 Tablets at room temperature, away from heat and moisture. Keep them out of reach of children.
Q:What should I do if I experience severe side effects?A:If you encounter serious side effects, such as symptoms of lactic acidosis, severe allergic reactions, or significant hypoglycemia, seek immediate medical attention.
